Developer docs
API playgroundTry for free, no card

Search company profiles

Teleflex

Full company profile

uuid0000rir

Namestring
Teleflex
Legal namestring
Teleflex Incorporated
Websiteurl
teleflex.com
Company typeenum
Public
Founded yearint
1943
Descriptiontext

Teleflex Incorporated (NYSE: TFX) is a global medical technology company founded in 1943 and headquartered in Wayne, Pennsylvania, with 10,000+ employees, manufacturing and R&D operations in Morrisville (NC) and Reading (PA), and commercial reach across the Americas, EMEA, and Asia Pacific. The company designs, manufactures, and sells a diversified portfolio of medical devices organized around Vascular Access (Arrow-branded CVCs, PICCs, antimicrobial catheters, and VPS tip-positioning systems), Emergency Medicine (EZ-IO intraosseous access, QuikClot hemostatic dressings), Interventional Cardiology/Radiology (MANTA vascular closure, Freesolve resorbable magnesium scaffold, GuideLiner catheters, IABP, plus the newly acquired BIOTRONIK coronary/peripheral portfolio), Surgical (Weck ligation, EFx Shield fascial closure, MiniLap), Urology (UroLift, Rüsch intermittent catheters, Barrigel rectal spacer), Anesthesia (LMA airways), and Military/Federal channels. Core technologies include antimicrobial catheter surface treatments (Arrowg+ard), Doppler/ECG-based catheter tip positioning (VPS), intraosseous vascular access (EZ-IO), bioresorbable magnesium alloy scaffolds (Freesolve/DREAMS 3G), and large-bore vascular closure (MANTA).

Teleflex generates revenue primarily through one-time hardware sales of capital equipment and consumable medical devices to hospitals, healthcare systems, and emergency/critical care providers, supplemented by service contracts and parts. Pricing is not publicly disclosed and is delivered through quote-based direct sales, the myTeleflex.com e-commerce portal, medical product distributors and wholesalers, GPO contracts, and specialized federal/military distributors. Customer segments span acute care hospitals, emergency departments and EMS, federal/military medical facilities (including VA and DoD), and ambulatory/alternate-site providers. FY2025 GAAP revenue from continuing operations reached $1,992.7 million, up 17.2% year-over-year, with Q1 2026 at $548.3 million.

Teleflex is mid-transformation: in 2025 it completed the acquisition of BIOTRONIK's Vascular Intervention business for approximately EUR 760 million, and it has announced ~$2.03 billion in after-tax divestiture proceeds from selling its Acute Care, Interventional Urology, and OEM businesses (expected H2 2026). New CEO Jason Weidman joined from Medtronic on June 8, 2026, leading a multi-year restructuring targeting $48–52 million in annual pre-tax savings. The company has 50+ years of consecutive dividend payments and trades on NYSE under TFX, with activist investor Irenic Capital (~2%) and reported take-private interest from CVC Capital Partners and GTCR in April 2026.

Short descriptiontext

Teleflex Incorporated is a global medical technology company that designs and sells vascular access, interventional, surgical, urology, anesthesia, and emergency medicine devices to hospitals, EMS providers, and federal/military healthcare facilities worldwide, with FY2025 revenue of $1.99B.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersWayne, United States
HQ citystring
Wayne
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device manufacturing, vascular access products, interventional cardiology devices, surgical instruments supply, airway management devices
Industry5 codes
PRIMARYHLAHAKAE
Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories)
SECONDARYHLAHAFAK
Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHADAL
Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAFAH
Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

Teleflex generates the majority of its revenue through the sale of medical devices, surgical instruments, vascular access products, and interventional solutions to hospitals and healthcare providers. Products are sold directly through sales representatives and through distribution channels. Revenue is primarily one-time purchase of capital equipment and consumable supplies, with some recurring revenue from service contracts and parts.

Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1Arrow
Description

Vascular access products including CVCs, PICCs, arterial catheters, and related accessories

teleflex.com
+8 more records
Core offering1 text field

Teleflex designs, develops, manufactures, and sells a broad portfolio of single-use and reusable medical devices organized across Vascular Access, Anesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology, Surgical, Urology, and Military-Federal product areas. Its flagship lines include Arrow-branded antimicrobial and central venous catheters, the VPS catheter tip-positioning system, EZ-IO intraosseous access, the MANTA vascular closure device, Freesolve bioresorbable magnesium scaffold, UroLift and Barrigel urology products, Weck surgical ligation/closure systems, LMA airway devices, and QuikClot hemostatic dressings.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Arrowg+ard Blue technology helps reduce catheter-related bloodstream infections in vascular access procedures
+1 more record
Product overview1 text field

Teleflex is a global provider of medical technologies organized into distinct product portfolios covering Vascular Access, Anesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology, Surgical, Urology, and Military-Federal markets. The company's core products include the Arrow-branded vascular access portfolio (Arrowg+ard antimicrobial catheters, VPS positioning systems, EZ-IO intraosseous systems), interventional devices (MANTA closure device, Freesolve resorbable scaffold, GuideLiner catheters, IABP), urology solutions (UroLift System, Barrigel, Rüsch catheters), surgical products (MiniLap, Weck ligation, EFx closure), and anesthesia/airway management (LMA airways, ISO-Gard mask). The portfolio is distributed across multiple product categories including central venous catheters, peripheral catheters, intermittent catheters, surgical instruments, and interventional devices, with key brands including Arrow, Rüsch, Weck, and LMA.

Product and service16 records
1Arrowg+ard Blue Plus CVC
CategoryVascular Access
Description

Antimicrobial central venous catheter with chlorhexidine/silver sulfadiazine protection against gram-positive bacteria, gram-negative bacteria, and fungi. Provides complete coverage including extension lines, hub and catheter, used by hospitals to reduce catheter-related bloodstream infections.

2Arrow VPS Rhythm DLX
CategoryVascular Access
Description

Catheter tip positioning system combining Doppler ultrasound, intravascular ECG and algorithmic logic to position catheters in the lower 1/3 of the SVC/CAJ. FDA cleared to replace chest X-ray confirmation, reducing procedure time and radiation exposure for clinicians and patients.

3EZ-IO Intraosseous Vascular Access System
CategoryEmergency Medicine
Description

Intraosseous vascular access system providing immediate access through bone for delivery of essential medications and fluids. Includes T.A.L.O.N. Needle Set and FAST1 Intraosseous Infusion System. Used by emergency departments, ICUs, EMS, and military medics when conventional IV access fails.

4Freesolve Resorbable Magnesium Scaffold
CategoryInterventional Cardiology/Radiology
Description

Resorbable magnesium scaffold (DREAMS 3G) for treating narrowed arteries. Designed to resorb within 12 months, potentially reducing long-term complications associated with permanent metallic implants. Under evaluation in the BIOMAG clinical trial program targeting interventional cardiology approval.

5UroLift System
CategoryInterventional Urology
Description

Minimally invasive device for treating benign prostatic hyperplasia (BPH). Clinical data showed significantly better catheter independence (3% vs. 20% for Rezum) and preserved sexual function through 12 months. Acquired with the NeoTract acquisition in 2017.

6Barrigel Rectal Spacer
CategoryInterventional Urology
Description

Rectal spacer product for prostate cancer patients undergoing radiation therapy. Demonstrated sustained reduction in radiation-associated gastrointestinal toxicity with zero percent Grade 2+ toxicity over three years versus 10 percent in the control arm. Acquired with the Palette Life Sciences acquisition in 2023.

7MANTA Vascular Closure Device
CategoryInterventional Cardiology/Radiology
Description

Vascular closure device for closure of femoral arterial access sites while reducing time to hemostasis following use of 10-20F devices or sheaths (12-25F OD) in endovascular catheterization procedures, including TAVR and large-bore interventional cases.

8LMA Airways
CategoryAnesthesia
Description

Supraglottic airway management devices for anesthesia and emergency medicine applications, including laryngeal mask airways used in operating rooms and emergency settings.

9MiniLap Percutaneous Surgical System
CategorySurgical
Description

Minimally invasive surgery product for percutaneous laparoscopy procedures, offering less traumatic access for surgeons performing laparoscopic procedures through smaller incisions.

10Weck Hem-o-lok Polymer Ligation System
CategorySurgical
Description

Polymer locking ligation system for surgical procedures, marketed as the standard in clip security for vessel and tissue ligation in laparoscopic and open surgery.

11Rüsch Intermittent Catheters
CategoryUrology
Description

Complete line of bladder management solutions including hydrophilic, uncoated, and closed system intermittent catheters, and Tiemann catheters for difficult catheterization, serving urology patients and intermittent self-catheterization users.

12Arrow OnControl Powered Bone Access System
CategoryEmergency Medicine
Description

Bone marrow aspiration and biopsy system for the iliac crest of adult and pediatric patients, and bone lesion biopsy of vertebral body. Used by hematologists and interventional radiologists.

13Arrow AC3 Optimus IABP
CategoryInterventional Cardiology/Radiology
Description

Intra-aortic balloon pump for acute coronary syndrome, cardiac/non-cardiac surgery, and heart failure complications, used in cardiac catheterization labs and cardiac surgery.

14GuideLiner V3 Catheter
CategoryInterventional Cardiology/Radiology
Description

Guide catheter used in conjunction with standard guide catheters to access discrete regions of coronary and peripheral vasculature, facilitate placement of interventional devices, and assist in crossing chronic total occlusions (CTO) in complex PCI and peripheral interventions.

15EFx Shield Fascial Closure System
CategorySurgical
Description

Fascial closure system providing confidence and control in surgical closure procedures, particularly for laparoscopic port-site closure and bariatric surgery.

16QuikClot Combat Gauze
CategoryMilitary-Federal
Description

Hemostatic dressings for military and emergency use, including QuikClot Combat Gauze which is the standard of care hemostatic gauze adopted by the U.S. military for battlefield hemorrhage control.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Teleflex acquired BIOTRONIK's Vascular Intervention business, adding a portfolio of coronary and peripheral vascular devices to Teleflex's product offerings. This strategic acquisition enhances Teleflex's position in the interventional cardiology and vascular surgery markets.

Strategic tierCoreTypeTechnology or Integration
Description

Teleflex partnered with o9 Solutions to implement their AI-powered demand planning and supply planning platform. This digital transformation initiative improves forecasting accuracy, supply chain efficiency, and inventory management across Teleflex's global operations.

3Premier Applied Sciences
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Teleflex partnered with Premier Applied Sciences for real-world evidence (RWE) research collaborations. This partnership supports clinical research initiatives and generates evidence demonstrating the effectiveness and value of Teleflex medical devices in real-world clinical settings.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global medical device incumbent competing directly with Teleflex across vascular access, interventional cardiology (where Medtronic recently settled a catheter patent case against Teleflex), and peripheral vascular. Weidman, Teleflex's incoming CEO, joins from Medtronic.

2Abbott
TypeDirect peer
Description

Direct competitor in interventional cardiology; its Xience DES is the comparator arm in Teleflex's BIOMAG-III pivotal trial of the Freesolve resorbable scaffold.

TypeDirect peer
Description

Direct competitor in central venous catheters, PICCs, and vascular access consumables, competing head-to-head with the Arrow portfolio at hospital GPOs.

TypeBroad incumbent
Description

Major interventional cardiology and peripheral vascular incumbent; competes with Teleflex in coronary and peripheral vascular intervention post-BIOTRONIK acquisition.

TypeDirect peer
Description

Direct competitor in vascular access (CVCs, PICC lines) and IV therapy after acquiring Smiths Medical, increasing scale and channel leverage against Teleflex's Arrow franchise.

TypeDirect peer
Description

Global medical device competitor across vascular access (CVCs, PICC lines), surgical instruments, and anesthesia delivery — directly comparable to Teleflex's Arrow and LMA franchises.

TypeBroad incumbent
Description

Cardiovascular device incumbent; competes in adjacent structural heart and critical care monitoring categories, with overlap in hospital cardiac procedural markets.

TypeBroad incumbent
Description

Surgical instruments and operating-room equipment competitor, with overlap in the Weck ligation, MiniLap percutaneous laparoscopic, and surgical closure categories.

TypeEmerging player
Description

Interventional vascular specialist growing in peripheral vascular thrombectomy and coronary; competes with Teleflex's GuideLiner and BIOTRONIK-acquired peripheral vascular portfolio.

TypeEmerging player
Description

Emerging interventional specialist in venous thromboembolism and peripheral vascular; represents a fast-growing competitor to Teleflex's peripheral vascular franchise.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A20 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Teleflex

Medical Devicesteleflex.com

Teleflex Incorporated is a global medical technology company that designs and sells vascular access, interventional, surgical, urology, anesthesia, and emergency medicine devices to hospitals, EMS providers, and federal/military healthcare facilities worldwide, with FY2025 revenue of $1.99B.

What Teleflex does

Teleflex Incorporated (NYSE: TFX) is a global medical technology company founded in 1943 and headquartered in Wayne, Pennsylvania, with 10,000+ employees, manufacturing and R&D operations in Morrisville (NC) and Reading (PA), and commercial reach across the Americas, EMEA, and Asia Pacific. The company designs, manufactures, and sells a diversified portfolio of medical devices organized around Vascular Access (Arrow-branded CVCs, PICCs, antimicrobial catheters, and VPS tip-positioning systems), Emergency Medicine (EZ-IO intraosseous access, QuikClot hemostatic dressings), Interventional Cardiology/Radiology (MANTA vascular closure, Freesolve resorbable magnesium scaffold, GuideLiner catheters, IABP, plus the newly acquired BIOTRONIK coronary/peripheral portfolio), Surgical (Weck ligation, EFx Shield fascial closure, MiniLap), Urology (UroLift, Rüsch intermittent catheters, Barrigel rectal spacer), Anesthesia (LMA airways), and Military/Federal channels. Core technologies include antimicrobial catheter surface treatments (Arrowg+ard), Doppler/ECG-based catheter tip positioning (VPS), intraosseous vascular access (EZ-IO), bioresorbable magnesium alloy scaffolds (Freesolve/DREAMS 3G), and large-bore vascular closure (MANTA).

Teleflex generates revenue primarily through one-time hardware sales of capital equipment and consumable medical devices to hospitals, healthcare systems, and emergency/critical care providers, supplemented by service contracts and parts. Pricing is not publicly disclosed and is delivered through quote-based direct sales, the myTeleflex.com e-commerce portal, medical product distributors and wholesalers, GPO contracts, and specialized federal/military distributors. Customer segments span acute care hospitals, emergency departments and EMS, federal/military medical facilities (including VA and DoD), and ambulatory/alternate-site providers. FY2025 GAAP revenue from continuing operations reached $1,992.7 million, up 17.2% year-over-year, with Q1 2026 at $548.3 million.

Teleflex is mid-transformation: in 2025 it completed the acquisition of BIOTRONIK's Vascular Intervention business for approximately EUR 760 million, and it has announced ~$2.03 billion in after-tax divestiture proceeds from selling its Acute Care, Interventional Urology, and OEM businesses (expected H2 2026). New CEO Jason Weidman joined from Medtronic on June 8, 2026, leading a multi-year restructuring targeting $48–52 million in annual pre-tax savings. The company has 50+ years of consecutive dividend payments and trades on NYSE under TFX, with activist investor Irenic Capital (~2%) and reported take-private interest from CVC Capital Partners and GTCR in April 2026.

Teleflex firmographics

Firmographics
Name
Teleflex
Legal name
Teleflex Incorporated
Website
https://teleflex.com
Company type
Public
Founded year
1943
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Teleflex Incorporated is a global medical technology company that designs and sells vascular access, interventional, surgical, urology, anesthesia, and emergency medicine devices to hospitals, EMS providers, and federal/military healthcare facilities worldwide, with FY2025 revenue of $1.99B.
Ownership category
akta.pro rank

Teleflex industry classification

Industry
Product category
Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAKAE
Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories)
SECONDARYHLAHAFAK
Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHADAL
Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAFAH
Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

  • Medical device manufacturing
  • Vascular access products
  • Interventional cardiology devices
  • Surgical instruments supply
  • Airway management devices

Where Teleflex is headquartered

Location

Headquarters

HQ city
Wayne
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Teleflex business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Medical Device Sales: Teleflex generates the majority of its revenue through the sale of medical devices, surgical instruments, vascular access products, and interventional solutions to hospitals and healthcare providers. Products are sold directly through sales representatives and through distribution channels. Revenue is primarily one-time purchase of capital equipment and consumable supplies, with some recurring revenue from service contracts and parts.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Teleflex product offering

Product offering

Core offering

Teleflex designs, develops, manufactures, and sells a broad portfolio of single-use and reusable medical devices organized across Vascular Access, Anesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology, Surgical, Urology, and Military-Federal product areas. Its flagship lines include Arrow-branded antimicrobial and central venous catheters, the VPS catheter tip-positioning system, EZ-IO intraosseous access, the MANTA vascular closure device, Freesolve bioresorbable magnesium scaffold, UroLift and Barrigel urology products, Weck surgical ligation/closure systems, LMA airway devices, and QuikClot hemostatic dressings.

Product overview

Teleflex is a global provider of medical technologies organized into distinct product portfolios covering Vascular Access, Anesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology, Surgical, Urology, and Military-Federal markets. The company's core products include the Arrow-branded vascular access portfolio (Arrowg+ard antimicrobial catheters, VPS positioning systems, EZ-IO intraosseous systems), interventional devices (MANTA closure device, Freesolve resorbable scaffold, GuideLiner catheters, IABP), urology solutions (UroLift System, Barrigel, Rüsch catheters), surgical products (MiniLap, Weck ligation, EFx closure), and anesthesia/airway management (LMA airways, ISO-Gard mask). The portfolio is distributed across multiple product categories including central venous catheters, peripheral catheters, intermittent catheters, surgical instruments, and interventional devices, with key brands including Arrow, Rüsch, Weck, and LMA.

Differentiator

Problem solved

Functional benefit

Brands

  • Arrow: Vascular access products including CVCs, PICCs, arterial catheters, and related accessories
  • Rüsch
  • Weck
  • EZ-IO
  • LMA
  • QuikClot
  • MANTA
  • UroLift
  • Barrigel

Products and services

  • Arrowg+ard Blue Plus CVC Antimicrobial central venous catheter with chlorhexidine/silver sulfadiazine protection against gram-positive bacteria, gram-negative bacteria, and fungi. Provides complete coverage including extension lines, hub and catheter, used by hospitals to reduce catheter-related bloodstream infections.
  • Arrow VPS Rhythm DLX Catheter tip positioning system combining Doppler ultrasound, intravascular ECG and algorithmic logic to position catheters in the lower 1/3 of the SVC/CAJ. FDA cleared to replace chest X-ray confirmation, reducing procedure time and radiation exposure for clinicians and patients.
  • EZ-IO Intraosseous Vascular Access System Intraosseous vascular access system providing immediate access through bone for delivery of essential medications and fluids. Includes T.A.L.O.N. Needle Set and FAST1 Intraosseous Infusion System. Used by emergency departments, ICUs, EMS, and military medics when conventional IV access fails.
  • Freesolve Resorbable Magnesium Scaffold Resorbable magnesium scaffold (DREAMS 3G) for treating narrowed arteries. Designed to resorb within 12 months, potentially reducing long-term complications associated with permanent metallic implants. Under evaluation in the BIOMAG clinical trial program targeting interventional cardiology approval.
  • UroLift System Minimally invasive device for treating benign prostatic hyperplasia (BPH). Clinical data showed significantly better catheter independence (3% vs. 20% for Rezum) and preserved sexual function through 12 months. Acquired with the NeoTract acquisition in 2017.
  • Barrigel Rectal Spacer Rectal spacer product for prostate cancer patients undergoing radiation therapy. Demonstrated sustained reduction in radiation-associated gastrointestinal toxicity with zero percent Grade 2+ toxicity over three years versus 10 percent in the control arm. Acquired with the Palette Life Sciences acquisition in 2023.
  • MANTA Vascular Closure Device Vascular closure device for closure of femoral arterial access sites while reducing time to hemostasis following use of 10-20F devices or sheaths (12-25F OD) in endovascular catheterization procedures, including TAVR and large-bore interventional cases.
  • LMA Airways Supraglottic airway management devices for anesthesia and emergency medicine applications, including laryngeal mask airways used in operating rooms and emergency settings.
  • MiniLap Percutaneous Surgical System Minimally invasive surgery product for percutaneous laparoscopy procedures, offering less traumatic access for surgeons performing laparoscopic procedures through smaller incisions.
  • Weck Hem-o-lok Polymer Ligation System Polymer locking ligation system for surgical procedures, marketed as the standard in clip security for vessel and tissue ligation in laparoscopic and open surgery.
  • Rüsch Intermittent Catheters Complete line of bladder management solutions including hydrophilic, uncoated, and closed system intermittent catheters, and Tiemann catheters for difficult catheterization, serving urology patients and intermittent self-catheterization users.
  • Arrow OnControl Powered Bone Access System Bone marrow aspiration and biopsy system for the iliac crest of adult and pediatric patients, and bone lesion biopsy of vertebral body. Used by hematologists and interventional radiologists.
  • Arrow AC3 Optimus IABP Intra-aortic balloon pump for acute coronary syndrome, cardiac/non-cardiac surgery, and heart failure complications, used in cardiac catheterization labs and cardiac surgery.
  • GuideLiner V3 Catheter Guide catheter used in conjunction with standard guide catheters to access discrete regions of coronary and peripheral vasculature, facilitate placement of interventional devices, and assist in crossing chronic total occlusions (CTO) in complex PCI and peripheral interventions.
  • EFx Shield Fascial Closure System Fascial closure system providing confidence and control in surgical closure procedures, particularly for laparoscopic port-site closure and bariatric surgery.
  • QuikClot Combat Gauze Hemostatic dressings for military and emergency use, including QuikClot Combat Gauze which is the standard of care hemostatic gauze adopted by the U.S. military for battlefield hemorrhage control.

Quantifiable outcome

  • Arrowg+ard Blue technology helps reduce catheter-related bloodstream infections in vascular access procedures
  • +1 more outcomes

Companies that use Teleflex

Customer profile

Segments4 records

Ideal customer profiles5 records

Teleflex technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature4 records

Teleflex partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered major, core and minor.

  • BIOTRONIKmajorStrategic or Co-development PartnerTeleflex acquired BIOTRONIK's Vascular Intervention business, adding a portfolio of coronary and peripheral vascular devices to Teleflex's product offerings. This strategic acquisition enhances Teleflex's position in the interventional cardiology and vascular surgery markets.
  • o9 SolutionscoreTechnology or IntegrationTeleflex partnered with o9 Solutions to implement their AI-powered demand planning and supply planning platform. This digital transformation initiative improves forecasting accuracy, supply chain efficiency, and inventory management across Teleflex's global operations.
  • Premier Applied SciencesminorStrategic or Co-development PartnerTeleflex partnered with Premier Applied Sciences for real-world evidence (RWE) research collaborations. This partnership supports clinical research initiatives and generates evidence demonstrating the effectiveness and value of Teleflex medical devices in real-world clinical settings.

Scale indicators5 records

Recent moves9 records

Expansion highlights6 records

Teleflex competitors and assessment

Company assessment

Broad incumbents

  • Medtronic: Global medical device incumbent competing directly with Teleflex across vascular access, interventional cardiology (where Medtronic recently settled a catheter patent case against Teleflex), and peripheral vascular. Weidman, Teleflex's incoming CEO, joins from Medtronic.
  • Boston Scientific: Major interventional cardiology and peripheral vascular incumbent; competes with Teleflex in coronary and peripheral vascular intervention post-BIOTRONIK acquisition.
  • Edwards Lifesciences: Cardiovascular device incumbent; competes in adjacent structural heart and critical care monitoring categories, with overlap in hospital cardiac procedural markets.
  • Stryker: Surgical instruments and operating-room equipment competitor, with overlap in the Weck ligation, MiniLap percutaneous laparoscopic, and surgical closure categories.

Direct peers

  • Abbott: Direct competitor in interventional cardiology; its Xience DES is the comparator arm in Teleflex's BIOMAG-III pivotal trial of the Freesolve resorbable scaffold.
  • Becton, Dickinson and Company (BD): Direct competitor in central venous catheters, PICCs, and vascular access consumables, competing head-to-head with the Arrow portfolio at hospital GPOs.
  • ICU Medical: Direct competitor in vascular access (CVCs, PICC lines) and IV therapy after acquiring Smiths Medical, increasing scale and channel leverage against Teleflex's Arrow franchise.
  • B. Braun: Global medical device competitor across vascular access (CVCs, PICC lines), surgical instruments, and anesthesia delivery — directly comparable to Teleflex's Arrow and LMA franchises.

Emerging players

  • Penumbra: Interventional vascular specialist growing in peripheral vascular thrombectomy and coronary; competes with Teleflex's GuideLiner and BIOTRONIK-acquired peripheral vascular portfolio.
  • Inari Medical: Emerging interventional specialist in venous thromboembolism and peripheral vascular; represents a fast-growing competitor to Teleflex's peripheral vascular franchise.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Teleflex social profiles

Digital presence

Teleflex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Teleflex leadership team

Management profile

Number of profiles

Profiles13 records

Teleflex subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Teleflex funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Teleflex M&A and investment

M&A and investment

M&A20 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Teleflex

What does Teleflex do?

Teleflex designs, develops, manufactures, and sells a broad portfolio of single-use and reusable medical devices organized across Vascular Access, Anesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology, Surgical, Urology, and Military-Federal product areas. Its flagship lines include Arrow-branded antimicrobial and central venous catheters, the VPS catheter tip-positioning system, EZ-IO intraosseous access, the MANTA vascular closure device, Freesolve bioresorbable magnesium scaffold, UroLift and Barrigel urology products, Weck surgical ligation/closure systems, LMA airway devices, and QuikClot hemostatic dressings.

Is Teleflex a public or private company?

Teleflex is a public company. It is classified as public and is currently operating.

When was Teleflex founded?

Teleflex was founded in 1943. It employs 5,001 to 10,000 people.

Where is Teleflex based?

Teleflex is headquartered in Wayne, United States, in the North America region.

How does Teleflex make money?

One revenue line is on record: medical Device Sales.

Who are Teleflex's main competitors?

Broad incumbents on record are Medtronic, Boston Scientific, Edwards Lifesciences and Stryker. Direct peers are Abbott, Becton, Dickinson and Company (BD), ICU Medical and B. Braun. Emerging players are Penumbra and Inari Medical.

Does Teleflex have an API?

No public API is recorded for Teleflex.

What industry is Teleflex in?

Teleflex's product category is Medical Devices. Its primary akta.pro industry code is HLAHAKAE, Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories), with a secondary code of HLAHAFAK, Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comTeleflex at Jefferies Global Healthcare Conference: focus shifts to integrationTeleflex CEO Jason Weidman outlined a transition plan at Jefferies, citing completed OEM divestiture and ongoing acute care and interventional urology sale. The company has deployed $600 million of its $1 billion buyback and paid down $700 million in debt, with BIOTRONIK integration improving. It expects a meaningful earnings lift in 2027.MarketWatchTeleflex Inc. stock outperforms competitors on strong trading dayTeleflex Inc. shares rose 1.56% to $159.55 on Tuesday, outperforming a weak market where the S&P 500 fell 1.03% and the Dow fell 1.64%. This was the company's third consecutive day of gains.MarketWatchTeleflex Inc. stock outperforms competitors on strong trading dayTeleflex Inc. shares rose 1.51% to $157.10 on Monday, outperforming a weak market where the S&P 500 fell 1.92% and the Dow fell 1.41%. The stock's second consecutive day of gains came despite the broader market decline.Simply Wall StEarnings Guidance Raise Could Be A Game Changer For Teleflex Stock (TFX)Teleflex reported Q3 2026 sales of $567.78 million and net income of $927.43 million, raising full-year GAAP EPS guidance despite a trimmed revenue outlook. The company repurchased 9.96% of shares and reaffirmed a $0.34 quarterly dividend. Management plans tuck-in acquisitions to support its margin roadmap.MarketWatchTeleflex Inc. stock outperforms competitors on strong trading dayTeleflex Inc. shares rose 1.27% to $155.10 on Friday, outperforming a mixed market session where the Dow rose 0.10% and the S&P fell 0.40%. The stock closed 1.05% below its 52-week high of $156.75, set on November 12th.MarketWatchTeleflex Inc. stock underperforms Thursday when compared to competitorsTeleflex Inc. shares fell 2.03% to $153.15 on Thursday, ending a three-day winning streak. The decline occurred amid a weak market session, with the S&P 500 down 0.35% and the Dow down 0.36%.Simply Wall StIncome Investors Should Know That Teleflex Incorporated (NYSE:TFX) Goes Ex-Dividend SoonTeleflex Incorporated is set to go ex-dividend in four days, with the record date on November 16 and payment on December 31. The dividend is US$0.34 per share, and the company paid out 67% of earnings and 16% of cash flow last year. Earnings per share have fallen about 21% annually over five years.